Literature DB >> 29866889

Comment to the article by Arai Y, Jo T, Matsui H, Kondo T and Takaori-Kondo A: "Comparison of up-front treatments for newly diagnosed immune thrombocytopenia - a systematic review and network meta-analysis". Haematologica 2018;103(1):163-171. Need to direct immune thrombocytopenia therapy towards shared goals.

Lorenzo Cirasino1, Stefano Semeraro2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29866889      PMCID： PMC6058789          DOI： 10.3324/haematol.2018.189183

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

Review 1.  Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis.

Authors:  Shaan Chugh; Saeed Darvish-Kazem; Wendy Lim; Mark A Crowther; Waleed Ghanima; Grace Wang; Nancy M Heddle; John G Kelton; Donald M Arnold
Journal:  Lancet Haematol       Date:  2015-02-05       Impact factor: 18.959

2.  Definition, diagnosis and treatment of immune thrombocytopenic purpura.

Authors:  James N George
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

3.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

4.  Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial.

Authors:  Bertrand Godeau; Sylvie Chevret; Bruno Varet; François Lefrère; Jean Marc Zini; François Bassompierre; Stéphane Chèze; Eric Legouffe; Cyrille Hulin; Marie José Grange; Olivier Fain; Philippe Bierling
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

Review 5.  Goals defining therapy for primary immune thrombocytopenia in adults.

Authors:  Lorenzo Cirasino; Stefano Semeraro
Journal:  Blood Coagul Fibrinolysis       Date:  2017-06       Impact factor: 1.276

Review 6.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

Review 7.  Can immune thrombocytopenia be cured with medical therapy?

Authors:  Adam Cuker; Eline T Luning Prak; Douglas B Cines
Journal:  Semin Thromb Hemost       Date:  2015-03-20       Impact factor: 4.180

Review 8.  ITP and international guidelines: what do we know, what do we need?

Authors:  Francesco Rodeghiero; Marco Ruggeri
Journal:  Presse Med       Date:  2014-03-20       Impact factor: 1.228

Review 9.  International consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Roberto Stasi; Adrian C Newland; Victor S Blanchette; Paula Bolton-Maggs; James B Bussel; Beng H Chong; Douglas B Cines; Terry B Gernsheimer; Bertrand Godeau; John Grainger; Ian Greer; Beverley J Hunt; Paul A Imbach; Gordon Lyons; Robert McMillan; Francesco Rodeghiero; Miguel A Sanz; Michael Tarantino; Shirley Watson; Joan Young; David J Kuter
Journal:  Blood       Date:  2009-10-21       Impact factor: 22.113

10.  Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis.

Authors:  Yasuyuki Arai; Tomoyasu Jo; Hiroyuki Matsui; Tadakazu Kondo; Akifumi Takaori-Kondo
Journal:  Haematologica       Date:  2017-09-29       Impact factor: 9.941
  10 in total
  1 in total

1.  Response to the Comment by Cirasino L and Semeraro S: "Need to direct immune thrombocytopenia therapy towards shared goals" Direct and indirect comparisons to determine the first choice for newly diagnosed primary immune thrombocytopenia in adults.

Authors:  Yasuyuki Arai; Tomoyasu Jo; Hiroyuki Matsui; Tadakazu Kondo; Akifumi Takaori-Kondo
Journal:  Haematologica       Date:  2018-06       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.